November 2025

Transforming Indian Healthcare for a Brighter Future The Indian healthcare system has come a long way, yet challenges persist. With a growing population, increasing healthcare demands, and the need for equitable access, India stands at a critical juncture. Transforming Indian healthcare is not just a necessity—it’s an opportunity to build a healthier, more prosperous nation. […]

Army Hospital Pioneers 3D Microscope for Glaucoma Surgery Breakthroughs In a groundbreaking development, an Army hospital has introduced a cutting-edge 3D microscope to revolutionize glaucoma surgery. This innovative technology promises to enhance precision, improve surgical outcomes, and reduce recovery times for patients suffering from this sight-threatening condition. With glaucoma affecting millions worldwide, this advancement could

Sanoculis Secures CE Mark for Innovative Glaucoma Treatment Device Introduction Sanoculis has achieved a major milestone by obtaining the CE Mark for its groundbreaking glaucoma treatment device. This approval enables the company to commercialize the technology across Europe, offering new hope to patients facing this sight-threatening condition. Glaucoma is a leading cause of irreversible blindness,

Pilocarpine Eye Drops Improve Outcomes After Kahook Dual Blade Goniotomy Introduction Glaucoma is a leading cause of irreversible blindness worldwide. Minimally invasive glaucoma surgeries (MIGS), such as the Kahook Dual Blade (KDB) goniotomy, effectively lower intraocular pressure (IOP). Recent studies show that combining KDB with pilocarpine eye drops can further enhance surgical outcomes. This article

CIME 2025: Community Collaboration Key to Glaucoma Care Glaucoma, often called the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. With millions affected and many unaware of their condition until significant vision loss occurs, the need for early detection and comprehensive care has never been greater. The upcoming CIME 2025 (Community

ARVO 2025: Breakthrough Cross-Attention Network for Glaucoma Detection Glaucoma, a leading cause of irreversible blindness worldwide, has long posed challenges for early detection and accurate diagnosis. However, a groundbreaking innovation unveiled at ARVO 2025 promises to revolutionize glaucoma screening—the Cross-Attention Network (CAN). This cutting-edge deep learning model leverages advanced attention mechanisms to enhance diagnostic precision,

Rare PTPRB Gene Linked to Eye and Vein Disorders Recent scientific discoveries have shed light on the role of the PTPRB gene in the development of rare eye and vein disorders. This gene, which encodes a protein tyrosine phosphatase, plays a crucial role in vascular development and maintenance. Mutations in PTPRB have now been linked

NESC Launches Innovative Eye Healthcare Software in Liberia In a groundbreaking move to revolutionize eye healthcare in Liberia, the National Eye Care Services (NESC) has introduced an innovative software solution designed to enhance diagnosis, treatment, and patient management. This cutting-edge technology aims to address the growing need for accessible and efficient eye care services across

Open Angle Glaucoma Clinical Trials and FDA Approvals 2025 Analysis Open-angle glaucoma (OAG) remains one of the leading causes of irreversible blindness worldwide. As research advances, 2025 is poised to be a pivotal year for clinical trials and FDA approvals in this space. This article delves into the latest developments, emerging therapies, and regulatory milestones

Does Glaucoma Run in Families? Hereditary Risks Explained Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. One of the most common questions patients ask is: does glaucoma run in families? The answer is yes—research shows that genetics play a significant role in glaucoma risk. Understanding the hereditary factors can help